FIELD: medicinal practice in clinical laboratories of radio nuclide diagnostics. SUBSTANCE: invention refers to examination of level of radioactivity of gamma-emitting radio pharmacological preparations based on Tc-99 before their injection to patients. Device has gamma- radiation detector with Geiger counters uniformly arranged around measurement volume. Geiger counters are fitted with calibrated lead shield mounted for movement and screening of measurement volume. Geiger counters are connected with their anodes to output of high-voltage unit and with their outputs to input of converter of signals from Geiger counters to digital form, the latter being connected with its multiposition output to multiposition input of unit computing and visualizing measurement results. EFFECT: simplified design and enhanced functional reliability of device. 1 cl, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF RADIONUCLIDAL DIAGNOSTICS OF BREAST CANCER | 2017 |
|
RU2682880C1 |
| METHOD FOR RADIONUCLIDE DIAGNOSTICS OF LUNG CANCER | 2020 |
|
RU2751103C1 |
| METHOD FOR RADIONUCLIDE DIAGNOSING OF CEREBRAL TUMORS | 2017 |
|
RU2692451C2 |
| METHOD FOR ASSESSING ABSORPTION FUNCTION OF SMALL INTESTINE | 2014 |
|
RU2553186C1 |
| METHOD FOR TARGETED BRACHYTHERAPY OF PROSTATE CANCER UNDER HYBRID PSMA-RECEPTOR SCINTIGRAPHY NAVIGATION | 2022 |
|
RU2788859C2 |
| METHOD FOR RADIONUCLIDE DIAGNOSIS OF PROSTATE CANCER | 2021 |
|
RU2776234C1 |
| METHOD FOR DIAGNOSTICS OF INFLAMMATORY PROCESS IN LUNGS AND IN INTRATHORACIC LYMPH NODES IN PATIENTS WITH SARCOIDOSIS | 2016 |
|
RU2638447C1 |
| METHOD FOR ESTIMATION OF FUNCTIONAL ACTIVITY OF RENAL PARENCHYMA | 2008 |
|
RU2392968C1 |
| METHOD FOR RADIONUCLIDEAN DIAGNOSTICS OF SECONDARY EDEMATOUS-INFILTRATIVE FORM OF BREAST CANCER WITH OVEREXPRESSION OF HER2/NEU USING RECOMBINANT ADDRESS MOLECULES DARPIN9_29 | 2019 |
|
RU2700109C1 |
| METHOD OF RADIONUCLIDAL DIAGNOSTICS OF LARYNGEAL AND PHARYNGOPHARYNGEAL CANCER | 2017 |
|
RU2679298C1 |
